VRX - Valeant Pharmaceuticals International

Profile for Valeant Pharmaceuticals International (VRX)

After Hours: $ 17.29

-0.20 (-1.14%)

Volume: 10.08 k

6:05 PM EST Nov 21, 2008

Business Description:
A pharmaceutical company, which develops, manufactures and markets a range of pharmaceutical products, in the areas of neurology, infectious disease and dermatology.

Address:

One Enterprise, Aliso Viejo, CA 92656

Telephone:

(949) 461-6000

Website:

www.valeant.com

Facsimile:

(949) 461-6609

Email:

ir@valeant.com

Details

CEO:

J. Michael Pearson

Employees:

3001

Market Cap:

1.43 b

Issue Type:

Common Stock

Auditor:

PRICEWATERHOUSECOOPERS LLP

Last Audit:

Unqualified

Indices:

DJ US Pharmaceuticals, Drug Manufacturers - Other, Russell 2000, S&P 1000 Pharmaceuticals Index, S&P 1500 Pharmaceuticals Index, S&P 400 Pharmaceuticals Index, S&P 900 Pharmaceuticals Index, S&P MidCap

Industry Classifications

Sector:

Healthcare

CIK:

0000930184

Industry:

Drugs

NAICS:

Pharmaceutical Preparation Manufacturing (325412)

QM ID:

Drug Manufacturers - Other (511)

SIC:

Pharmaceutical Preparations (2834) , In Vitro And In Vivo Diagnostic Substances (2835) , Surgical And Medical Instruments And Apparatus (3841)

Profitability

Management Effectiveness

Gross Margin:

72.20

Return on Equity:

24.70

EBIT Margin:

3.00

Return on Capital:

12.60

Profit Margin:

-1.50

Return on Assets:

9.70

Share Statistics

Outstanding:

81.5 m

Float:

79.28 m

Short Interest:

17.13 m (as of 10/28/08)

Short Int Ratio:

10.90

% of Float:

21.60%

Non-Corp. Insider Hold'gs:

2.50% (as of 9/1/08)

Bought Prev 3 Mo:

838.19 k

Sold Prev 3 Mo:

Institution Hold'gs:

(as of 10/1/08)

Total Held:

109.99 m

Institutions:

194

Bought Prev Mo:

8.25 m

Sold Prev Mo:

3.44 m